Group Director
Michiaki KUBO
(M.D., Ph.D.)

Research Areas

Main aims of Research group for genotyping are the creation of large-scale genetic information and the development of innovative technology for the realization of Personalized Medicine. For these aims, Laboratory for Genotyping Development is working on the genotyping of genome-wide association studies for common diseases, innovation of new genotyping method for genetic variation, and the application of our genotyping method for clinical use. Laboratory for Biomarker Development is working on the whole-genome sequencing using next generation sequencer and the development of biomarkers for human diseases by proteomics analysis.

Press release

November 19, 2009

Identification of three genes involved in the onset of the incurable ulcerative colitis disease

RIKEN RESEARCH

March 05, 2010

Japanese genomes inform on gut inflammation culprits
Revealing genes linked to the inflammatory bowel disease ulcerative colitis may speed the development of treatments

• Laboratory for Genotyping Development
• Laboratory for Biomarker Development